ACSRX
Price
$28.38
Change
-$0.77 (-2.64%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

ACSRX vs RMFCX

Header iconACSRX vs RMFCX Comparison
Open Charts ACSRX vs RMFCXBanner chart's image
Invesco Comstock R
Price$28.38
Change-$0.77 (-2.64%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
ACSRX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ACSRX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACSRX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. ACSRX (12.2B). RMFCX pays higher dividends than ACSRX: RMFCX (1.69) vs ACSRX (1.28). ACSRX was incepted earlier than RMFCX: ACSRX (22 years) vs RMFCX (23 years). RMFCX is a more actively managed with annual turnover of: 25.00 vs. ACSRX (21.00). ACSRX has a lower initial minimum investment than RMFCX: ACSRX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. ACSRX (9.14). RMFCX return over 5 years is better than : 40.39 vs. ACSRX (24.27).
ACSRXRMFCXACSRX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years23 years-
Gain YTD8.14011.42371%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets12.2B98.7B12%
Annual Yield % from dividends1.281.6975%
Returns for 1 year9.1412.6372%
Returns for 3 years6.4214.1645%
Returns for 5 years24.2740.3960%
Returns for 10 years26.6261.8443%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc